ロード中...
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials
AIMS/HYPOTHESIS: Delayed-release metformin (Metformin DR) was developed to maximise gut-based mechanisms of metformin action by targeting the drug to the ileum. Metformin DR was evaluated in two studies. Study 1 compared the bioavailability and effects on circulating glucose and gut hormones (glucag...
保存先:
| 出版年: | Diabetologia |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4930485/ https://ncbi.nlm.nih.gov/pubmed/27216492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-016-3992-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|